[{"Assets_0_Q3_USD":103684000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-48918000.0,"NetIncomeLoss_1_Q3_USD":-23922000.0,"NetIncomeLoss_3_Q3_USD":-57892000.0,"StockholdersEquity_0_Q3_USD":85939000.0,"Ticker":"YMAB","CIK":"1722964","name":"Y-MABS THERAPEUTICS, INC.","OfficialName":"Y-mAbs Therapeutics Inc. Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"556910423.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20191113"}]